U.S. Physical Therapy (NYSE:USPH) Reaches New 12-Month High Following Better-Than-Expected Earnings

Key Points

• U.S. Physical Therapy beat quarterly earnings and revenue expectations: EPS was $0.80 versus $0.76 forecast, while revenue of $222.56 million exceeded estimates of $214.48 million and rose 12.9% year over year.
• Shares reached a new 52-week high of $100.98 after previously closing at $89.18.
• The company announced a quarterly dividend of $0.46 per share, equivalent to an annualized yield of about 1.9%; analysts’ consensus rating was “Moderate Buy,” with a $98.25 target price.

U.S. Physical Therapy, Inc. (NYSE:USPH - Get Free Report)'s stock price hit a new 52-week high on Thursday following a better than expected earnings announcement. The company traded as high as $100.98 and last traded at $99.4060, with a volume of 19,499 shares traded. The stock had previously closed at $89.18.

The company reported $0.80 earnings per share for the quarter, beating analysts' consensus estimates of $0.76 by $0.04. U.S. Physical Therapy had a return on equity of 9.39% and a net margin of 3.97%. The company had revenue of $222.56 million during the quarter, compared to analyst estimates of $214.48 million. During the same period last year, the company posted $0.66 earnings per share. The firm's quarterly revenue was up 12.9% compared to the same quarter last year.

U.S. Physical Therapy Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, December 11th. Shareholders of record on Monday, November 16th will be given a dividend of $0.46 per share. The ex-dividend date is Monday, November 16th. This represents a $1.84 dividend on an annualized basis and a yield of 1.9%. U.S. Physical Therapy's dividend payout ratio is presently 1,082.35%.

Wall Street Analyst Weigh In

USPH has been the topic of a number of research analyst reports. Citigroup reaffirmed a "market outperform" rating on shares of U.S. Physical Therapy in a report on Wednesday, August 19th. JPMorgan Chase & Co. raised their target price on U.S. Physical Therapy from $90.00 to $95.00 and gave the company an "overweight" rating in a report on Friday, September 11th. Barrington Research increased their price objective on shares of U.S. Physical Therapy from $90.00 to $98.00 and gave the company an "outperform" rating in a research note on Monday, August 10th. Finally, Weiss Ratings reaffirmed a "hold (c-)" rating on shares of U.S. Physical Therapy in a report on Wednesday, August 26th. One investment analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating and two have assigned a Hold rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $98.25.

Institutional Trading of U.S. Physical Therapy

Institutional investors have recently modified their holdings of the business. Fulcrum Asset Management LLP acquired a new stake in U.S. Physical Therapy during the 3rd quarter worth about $35,000. Pictet Asset Management Holding SA bought a new stake in U.S. Physical Therapy during the 3rd quarter worth approximately $218,000. Integrity Alliance LLC. purchased a new position in shares of U.S. Physical Therapy during the third quarter valued at approximately $799,000. Bridge City Capital LLC raised its position in U.S. Physical Therapy by 18.7% in the 3rd quarter. Bridge City Capital LLC now owns 80,585 shares of the company's stock valued at $6,909,000 after buying an additional 12,695 shares during the last quarter. Finally, Verdence Capital Advisors LLC bought a new position in U.S. Physical Therapy during the 3rd quarter valued at $232,000.

U.S. Physical Therapy Stock Up 10.7%

The company has a current ratio of 1.27, a quick ratio of 1.27 and a debt-to-equity ratio of 0.48. The stock has a market capitalization of $1.47 billion, a PE ratio of 580.89, a P/E/G ratio of 2.15 and a beta of 1.16. The stock's fifty day simple moving average is $83.40 and its 200-day simple moving average is $76.92.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc NYSE: USPH operates outpatient physical therapy clinics throughout the United States. The company provides treatment and rehabilitation services for patients recovering from injuries, surgeries, illnesses and other conditions that affect movement, strength and physical function.

In addition to company-operated clinics, U.S. Physical Therapy develops and manages physical therapy practices in partnership with local physical therapists. Its services generally include orthopedic and sports rehabilitation, post-operative therapy, treatment for musculoskeletal conditions and other forms of outpatient rehabilitation.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.